157 related articles for article (PubMed ID: 35458579)
1. Modelling of Breath and Various Blood Volatilomic Profiles-Implications for Breath Volatile Analysis.
Mochalski P; King J; Mayhew CA; Unterkofler K
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458579
[TBL] [Abstract][Full Text] [Related]
2. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
[TBL] [Abstract][Full Text] [Related]
3. Variation of volatile organic compound levels within ambient room air and its impact upon the standardisation of breath sampling.
Hewitt MJ; Belluomo I; Zuffa S; Boshier PR; Myridakis A
Sci Rep; 2022 Sep; 12(1):15887. PubMed ID: 36151300
[TBL] [Abstract][Full Text] [Related]
4. A literature survey of all volatiles from healthy human breath and bodily fluids: the human volatilome.
Drabińska N; Flynn C; Ratcliffe N; Belluomo I; Myridakis A; Gould O; Fois M; Smart A; Devine T; Costello BL
J Breath Res; 2021 Apr; 15(3):. PubMed ID: 33761469
[TBL] [Abstract][Full Text] [Related]
5. Assessment, origin, and implementation of breath volatile cancer markers.
Haick H; Broza YY; Mochalski P; Ruzsanyi V; Amann A
Chem Soc Rev; 2014 Mar; 43(5):1423-49. PubMed ID: 24305596
[TBL] [Abstract][Full Text] [Related]
6. The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva.
Amann A; Costello Bde L; Miekisch W; Schubert J; Buszewski B; Pleil J; Ratcliffe N; Risby T
J Breath Res; 2014 Sep; 8(3):034001. PubMed ID: 24946087
[TBL] [Abstract][Full Text] [Related]
7. Volatile compounds in blood headspace and nasal breath.
Ross BM; Babgi R
J Breath Res; 2017 Sep; 11(4):046001. PubMed ID: 28671107
[TBL] [Abstract][Full Text] [Related]
8. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
[TBL] [Abstract][Full Text] [Related]
9. Pitfalls in the analysis of volatile breath biomarkers: suggested solutions and SIFT-MS quantification of single metabolites.
Smith D; Spanel P
J Breath Res; 2015 Apr; 9(2):022001. PubMed ID: 25830501
[TBL] [Abstract][Full Text] [Related]
10. A mathematical model for breath gas analysis of volatile organic compounds with special emphasis on acetone.
King J; Unterkofler K; Teschl G; Teschl S; Koc H; Hinterhuber H; Amann A
J Math Biol; 2011 Nov; 63(5):959-99. PubMed ID: 21234569
[TBL] [Abstract][Full Text] [Related]
11. Physiological variability in volatile organic compounds (VOCs) in exhaled breath and released from faeces due to nutrition and somatic growth in a standardized caprine animal model.
Fischer S; Trefz P; Bergmann A; Steffens M; Ziller M; Miekisch W; Schubert JS; Köhler H; Reinhold P
J Breath Res; 2015 May; 9(2):027108. PubMed ID: 25971714
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties.
Amann A; Mochalski P; Ruzsanyi V; Broza YY; Haick H
J Breath Res; 2014 Mar; 8(1):016003. PubMed ID: 24566039
[TBL] [Abstract][Full Text] [Related]
13. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
[TBL] [Abstract][Full Text] [Related]
14. Volatile disease biomarkers in breath: a critique.
Kwak J; Preti G
Curr Pharm Biotechnol; 2011 Jul; 12(7):1067-74. PubMed ID: 21466456
[TBL] [Abstract][Full Text] [Related]
15. Prediction of blood:air and fat:air partition coefficients of volatile organic compounds for the interpretation of data in breath gas analysis.
Kramer C; Mochalski P; Unterkofler K; Agapiou A; Ruzsanyi V; Liedl KR
J Breath Res; 2016 Jan; 10(1):017103. PubMed ID: 26815030
[TBL] [Abstract][Full Text] [Related]
16. Factors that influence the volatile organic compound content in human breath.
Blanchet L; Smolinska A; Baranska A; Tigchelaar E; Swertz M; Zhernakova A; Dallinga JW; Wijmenga C; van Schooten FJ
J Breath Res; 2017 Feb; 11(1):016013. PubMed ID: 28140379
[TBL] [Abstract][Full Text] [Related]
17. A breath sampling system assessing the influence of respiratory rate on exhaled breath composition.
Lomonaco T; Salvo P; Ghimenti S; Biagini D; Bellagambi F; Fuoco R; Di Francesco F
Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():7618-21. PubMed ID: 26738056
[TBL] [Abstract][Full Text] [Related]
18. Machine learning analysis of volatolomic profiles in breath can identify non-invasive biomarkers of liver disease: A pilot study.
Thomas JN; Roopkumar J; Patel T
PLoS One; 2021; 16(11):e0260098. PubMed ID: 34847181
[TBL] [Abstract][Full Text] [Related]
19. Dynamic Stability of Volatile Organic Compounds in Respiratory Air in Schizophrenic Patients and Its Potential Predicting Efficacy of TAAR Agonists.
Held A; Henning D; Jiang C; Hoeschen C; Frodl T
Molecules; 2023 May; 28(11):. PubMed ID: 37298866
[TBL] [Abstract][Full Text] [Related]
20. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
